KYTX (Kyverna Therapeutics Inc.) Sof foyda

KYTX (Kyverna Therapeutics, Inc.) - kompaniyaning tovar belgisi

Kyverna Therapeutics (KYTX) organizmning himoya funksiyalarini kuchaytirish uchun innovatsion terapiyalarni ishlab chiqishga ixtisoslashgan. Joriy aksiya narxining ushbu grafigi foydasi -0.15 miqdorida bo'lgan aktiv dinamikasini aks ettiradi. Hujayra terapiyasi uchun ishlab chiqarish sikllari tasdiqlangan apparatlar bilan jihozlangan tibbiyot markazlarida optimallashtirilgan. Biroq, tijorat sotuvlarining yo'qligi va investitsiyalarga bog'liqlik kompaniyaning pul oqimlarini oldindan aytib bo'lmaydigan holga keltirmoqda.

KYTX (Kyverna Therapeutics) Sof foyda tarixi 21.02.2024dan 01.11.2026gacha

Kyverna Therapeutics, Inc. (KYTX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Kyverna Therapeutics, Inc|KYTX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Kyverna Therapeutics, Inc|KYTX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Kyverna Therapeutics|KYTX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi kyvernatx.com|KYTX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Kyverna Therapeutics|KYTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Kyverna Therapeutics Inc.|KYTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Kyverna Therapeutics, Inc|KYTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Kyverna Therapeutics|Shoshilinch likvidlik kyvernatx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
KYTX - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Kyverna Therapeutics
Kyverna asosiy tovari

Foyda operatsion samaradorlikni aktivning bozor narxi bilan solishtirish orqali biznesning kundalik kapital qiymatini o'lchaydi. Investor haqiqiy daromad va kotirovkalar orasidagi farqni tahlil qilish orqali modelning barqarorligini aniqlaydi. Kompaniyaning joriy foyda darajasini baholash orqali chuqur pasayishlar xavfini aniqlash mumkin. Kyverna Therapeutics (KYTX) uchun moliyaviy natija bevosita klinik sinovlar bosqichlariga bog'liq. Avtoimmun kasalliklar uchun hujayra terapiyasiga bo'lgan talab iqtisodiy sikllardan qat'i nazar barqaror qolmoqda.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|PHAR - Sof foyda|NKTR (Nektar Therapeutics) - Sof daromad|Kompaniyaning sof daromadi upstreambio.com (UPB)|Sof daromad ZBIO|Kompaniyaning sof foydasi IMNM|Sof foyda GOSS|KALV - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Septerna Inc SEPN|Yakuniy foyda PVLA|SVRA - Kompaniyaning sof foydasi|RIGL (Rigel Pharma) - Kompaniya foydasi|ANAB: Sof foyda|Astria Corp (ATXS) - Sof foyda|Sof daromad ENGN|RAPT: Yakuniy foyda|Sof daromad JBIO (Aerovate Therapeutics Inc)|Soliqlar to‘langandan keyingi foyda ACRS|Sof foyda TLSA (Tiziana Life Sciences PLC)|Yakuniy foyda CABA|Ventyx Biosciences - Sof foyda|Kompaniyaning sof daromadi theratech.com|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|Eledon Pharmaceuticals Inc. - Yakuniy foyda|AGEN (Agenus Inc) - Sof foyda|Sof foyda Climb Bio, Inc|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR: Soliqdan keyingi foyda|Sof foyda ADAG (Adagene Inc.)|ImageneBio (IMA) - Kompaniyaning sof daromadi|STTK: Sof daromad|EQ - Sof foyda|CNTB (connectbiopharm.com) - Sof daromad|IMUX: Soliqlar to‘langandan keyingi foyda|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Sof foyda XFOR|Sof daromad adicetbio.com ACET|Kompaniyaning sof foydasi Celularity CELU|Sof moliyaviy natija inmunebio.com (INMB)|BRNS - Kompaniyaning sof foydasi|KZR - Sof foyda|SABS (SAB Biotherapeutics, Inc) - Sof daromad|Kompaniyaning sof daromadi Akari Therapeutics, Plc (AKTX)|Sof daromad ENLV|QTTB (Q32 Bio Corp) - Soliqlar to‘langandan keyingi foyda|Sof daromad GOVX (GeoVax)|Edesa Biotech Inc - Kompaniya foydasi|Kompaniyaning sof foydasi iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Soliqdan keyingi foyda|XTL Biopharmaceuticals - Sof foyda|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|ADTX: Yakuniy foyda|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi